arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

BeyondSpring Inc.

BYSI
$0.75 ▲ +0.02 (+2.81%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
12 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Neutral
auto_awesome

Analytical Summary

BeyondSpring Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap —
Dividend Yield —
Revenue Growth None
Op. Margin —
ROIC 28.1% ↗
FCF / Share None
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 21, 2026.

12-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
— —
Net Income Profit after all expenses
$-1.01M
↑ +91.0% —
FCF / Share Free cash flow per share
$-0.70
↑ +45.2% —
Long-Term Debt Long-term obligations
$2.17M
↑ +50.9% —

Health Breakdown

Returns
50
Cash Quality ↑
99

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 12 years · 20 quarters